Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Gene-expression data for SKH1 mice receiving doxorubicin, hindlimb radiation therapy or both

ABSTRACT: Gene-expression data for SKH1 mice receiving doxorubicin, hindlimb radiation therapy or both

PROVIDER: PRJNA986478 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Similar Datasets

Gene-expression data for SKH1 mice receiving hindlimb radiation therapy [Glial_Panel]

Project description:Gene-expression data for SKH1 mice receiving hindlimb radiation therapy [Glial_Panel]

| PRJNA1101030 | ENA

Gene-expression data for SKH1 mice receiving hindlimb radiation therapy [Neuroinflammation Panel]

Project description:Gene-expression data for SKH1 mice receiving hindlimb radiation therapy [Neuroinflammation Panel]

| PRJNA1101029 | ENA

Gene-expression data for SKH1 mice receiving doxorubicin, hindlimb radiation therapy or both

Project description:NanoString nCounter Glial Profiling Panel

2023-12-23 | GSE235567 | GEO

Transcription profiling of doxorubicin sensitive and resistant human myeloma cell lines after treatment with doxorubicin to explore the role of the STAT1 signaling pathway in drug and radiation resistance

Project description:The myeloma cell line RPMI 8226/S and its doxorubicin resistant subline 8226/Dox40 were used as models to explore the potential importance of the STAT1 signaling pathway in drug and radiation resistance. The 40-fold doxorubicin resistant subline 8226/Dox40 was found to be crossresistant to single doses of 4 and 8 Gy of radiation. A genome-wide mRNA expression study comparing the 8226/Dox40 cell line to its parental line was performed to identify the underlying molecular mechanisms. Seventeen of the top 50 overexpressed genes have previously been implicated in the STAT1 signaling pathway. STAT1 was over expressed both at the mRNA and protein level. Moreover, analyses of nuclear extracts showed higher abundance of phosphorylated STAT1 (Tyr 701) in the resistant subline. Preexposure of the crossresistant cells to the STAT1 inhibiting drug fludarabine reduced expression of overexpressed genes and enhanced the effects of both doxorubicin and radiation. These results show that resistance to doxorubicin and radiation is associated with increased STAT1 signaling and can be modulated by fludarabine. The data support further development of therapies combining fludarabine and radiation.

2007-01-10 | E-BASE-2 | biostudies-arrayexpress

Genomic profile of fatigued men receiving localized radiation therapy

Project description:Microarray gene expression of peripheral blood of the prostate cancer patients receiving localized external beam radiation therapy (EBRT) Assay processed at EBRT time points, baseline, midpoint (days 19-21) and endpoint (days 38-42)

2015-06-17 | GSE69961 | GEO

Targeting OCT3 attenuates doxorubicin-induced cardiac injury

Project description:Doxorubicin is a commonly used anticancer agent that can cause debilitating and irreversible cardiac injury. The initiating mechanisms contributing to this side effect remain unknown, and current preventative strategies only offer modest protection. Using stem cell-derived cardiomyocytes from patients receiving doxorubicin, we probed the transcriptomic landscape of solute carriers and identified OCT3 (SLC22A3) as a critical transporter regulating the cardiac accumulation of doxorubicin. Functional validation studies in mice revealed that targeting OCT3 can attenuate cardiac dysfunction without compromising the anticancer properties of doxorubicin. These findings provide a rationale for the development of targeted approaches to mitigate this debilitating toxicity

2021-02-19 | GSE157904 | GEO

Hindlimb suspension and reloading study

Project description:Analysis of effect of hindlimb suspension and reloading on C57Bl/6 mouse soleus muscle. Experimental groups examined: -Control mice, 14 days -Hindlimb suspension for 7 days -Hindlimb suspension for 7 days, and subsequent reloading for 1 day -Hindlimb suspension for 7 days, and subsequent reloading for 7 days

2010-06-05 | E-GEOD-1293 | biostudies-arrayexpress

Hindlimb suspension and reloading study

2004-09-30 | GSE1293 | GEO

Detoxifying doxorubicin

Project description:Detoxifying doxorubicin

| PRJNA422761 | ENA

Hindlimb suspension

Project description:Hindlimb suspended for 7 days Keywords: repeat sample

2004-09-30 | GSE1285 | GEO